324 related articles for article (PubMed ID: 25450536)
1. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
[No Abstract] [Full Text] [Related]
3. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
[TBL] [Abstract][Full Text] [Related]
4. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis.
Tsantes AE; Nikolopoulos GK; Bagos PG; Rapti E; Mantzios G; Kapsimali V; Travlou A
Thromb Haemost; 2007 Jun; 97(6):907-13. PubMed ID: 17549286
[TBL] [Abstract][Full Text] [Related]
5. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
[TBL] [Abstract][Full Text] [Related]
6. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ
Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255
[TBL] [Abstract][Full Text] [Related]
7. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH
Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis.
Huang Z; Tang W; Liang Z; Chen Q; Li M; Li Y; Lao S; Pan H; Huang L; Huang M; Hu X; Zhao J
Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
Sundquist K; Wang X; Svensson PJ; Sundquist J; Hedelius A; Larsson Lönn S; Zöller B; Memon AA
Thromb Haemost; 2015 Nov; 114(6):1156-64. PubMed ID: 26245493
[TBL] [Abstract][Full Text] [Related]
10. Genetic association between plasminogen activator inhibitor-1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta-analysis.
Huang G; Wang P; Li T; Deng X
Clin Cardiol; 2019 Dec; 42(12):1232-1238. PubMed ID: 31701558
[TBL] [Abstract][Full Text] [Related]
11. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
12. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
Schenk JF; Stephan B; Zewinger S; Speer T; Pindur G
Clin Hemorheol Microcirc; 2008; 39(1-4):329-32. PubMed ID: 18503142
[TBL] [Abstract][Full Text] [Related]
14. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
Gohil R; Peck G; Sharma P
Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
[TBL] [Abstract][Full Text] [Related]
15. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
Nie W; Li B; Xiu QY
PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
[TBL] [Abstract][Full Text] [Related]
16. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.
Zhang X; Gao B; Xu B
Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353
[TBL] [Abstract][Full Text] [Related]
17. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis.
Barcellona D; Fenu L; Cauli C; Pisu G; Marongiu F
Thromb Haemost; 2003 Dec; 90(6):1061-4. PubMed ID: 14652637
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
20. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
